Africa has a substantial sickle-cell disease (SCD) and beta-thalassemia burden - making oral iron chelation a regional public-health priority. Procurement teams across the continent navigate a diverse regulatory landscape and varied channel structures.
1. Regulatory Landscape #
| Country | Regulator |
|---|---|
| Nigeria | NAFDAC |
| Kenya | Pharmacy and Poisons Board (PPB) |
| Tanzania | TMDA (formerly TFDA) |
| Uganda | National Drug Authority (NDA) |
| Ghana | Food and Drugs Authority (FDA Ghana) |
| Ethiopia | EFDA |
| South Africa | SAHPRA |
| Zimbabwe | MCAZ |
2. Channel Structures #
- Public-sector tenders (ministries of health, central medical stores - KEMSA, CMS Tanzania, NHLMIS)
- Faith-based hospital networks (CHAK, MEDS)
- Private specialty pharmacies in urban centres
- Donor and NGO channels for SCD / thalassemia programmes
3. What Procurement Teams Should Look For #
- WHO-GMP certificate from a credible manufacturer
- WHO-format CoPP for the target strength
- Local registration status or active submission
- ICH Q1A Zone IVb stability data (relevant for most of Africa)
- Demonstrated supply reliability to African customers
- Bioequivalence summary
4. Common Procurement Pitfalls #
- Trader-only supply with no manufacturer accountability
- Stability data only for temperate zones
- Delayed customs clearance due to missing documentation
- Price-only selection ignoring quality differentiation
5. Taj Pharma in Africa #
DEFRATAJ Deferasirox is supplied to African markets through qualified distributors and direct tender participation. Five-strength range (100/125/250/400/500 mg) supports pediatric and adult dosing - especially relevant given the high SCD pediatric burden. See Nigeria and Kenya landers.